NCT06115824
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Department of Hematology, Huashan Hospital, Fudan University Shanghai, China
Clinical trial condition
Primary Central Nervous System Lymphoma
Explore clinical trials studying Primary Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.
38 public trials
17 recruiting studies
Primary Central Nervous System Lymphoma trial results
NCT05390814
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Hôpital Pitié Salpêtrière Paris, France
NCT03495960
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
- Odense University Hospital Odense, Denmark
- Oulu University Hospital Oulu, Finland
- Tampere University Hospital Tampere, Finland
NCT06454266
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- The First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
NCT01421524
- Conditions
- Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- UCLA Neuro-Oncology Program Los Angeles, California, United States
- UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
- University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT03255018
- Conditions
- Diffuse Large B-cell Lymphoma, Gray-zone Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma
NCT04934579
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT01647971
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
- Locations
-
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
- TG Therapeutics Investigational Trial Site Athens, Georgia, United States
- TG Therapeutics Investigational Trial Site Macon, Georgia, United States
NCT02669511
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
Not specified
NCT02301364
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering West Harrison Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States